| Characteristic | N | % |
| Sex: |
|
|
| Male | 24 | 54.5 |
| Female | 20 | 45.5 |
| Age: median 57 years |
|
|
| ≤60 Y | 18 | 40.9 |
| >60 Y | 26 | 59.1 |
| Pathology |
|
|
| CLL/SLL | 2 | 4.5 |
| Follicular lymphoma |
|
|
| Grade 1 | 22 | 50 |
| Grade 2 | 18 | 41 |
| MALT | 2 | 4.5 |
| Number of prior regimens |
|
|
| 0 - 2 | 28 | 63.7 |
| 3 - 5 | 16 | 36.3 |
| Number of involved sites |
|
|
| 1 - 2 | 30 | 68.2 |
| 3 - 5 | 14 | 31.8 |
| Size of the largest lymph node |
|
|
| ≤5 cm | 17 | 38.6 |
| >5 cm | 27 | 61.4 |
| LDH |
|
|
| High | 31 | 70.4 |
| Normal | 13 | 29.6 |
| Time since diagnosis, median = 42 months |
|
|
| ≤24 months | 12 | 27.3 |
| 25 - 60 months | 15 | 34.1 |
| 61 - 120 months | 10 | 22.7 |
| ≥120 months | 7 | 15.9 |